BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schmidt ML, Hoffmann L, Kandi M, Møller DS, Poulsen PR. Dosimetric impact of respiratory motion, interfraction baseline shifts, and anatomical changes in radiotherapy of non-small cell lung cancer. Acta Oncol 2013;52:1490-6. [PMID: 23905673 DOI: 10.3109/0284186X.2013.815798] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 4.9] [Reference Citation Analysis]
Number Citing Articles
1 Zhou S, Meng Y, Sun X, Jin Z, Feng W, Yang H. The critical components for effective adaptive radiotherapy in patients with unresectable non-small-cell lung cancer: who, when and how. Future Oncol 2022. [PMID: 36189758 DOI: 10.2217/fon-2022-0291] [Reference Citation Analysis]
2 Sarudis S, Karlsson A, Nyman J, Bäck A. Dosimetric effects of respiratory motion during stereotactic body radiation therapy of lung tumors. Acta Oncol 2022;:1-8. [PMID: 35905048 DOI: 10.1080/0284186X.2022.2092420] [Reference Citation Analysis]
3 Lei Y, Tian Z, Qiu R, Wang T, Roper J, Higgins K, Bradley JD, Liu T, Yang X. Deep-learning-based markerless tumor localization using 2D KV/MV image. Medical Imaging 2022: Image Processing 2022. [DOI: 10.1117/12.2611823] [Reference Citation Analysis]
4 Lei Y, Tian Z, Wang T, Axente M, Roper J, Higgins K, Bradley JD, Liu T, Yang X. Fast 3D imaging via deep learning for deep inspiration breath-hold lung radiotherapy. Medical Imaging 2022: Image-Guided Procedures, Robotic Interventions, and Modeling 2022. [DOI: 10.1117/12.2611813] [Reference Citation Analysis]
5 Li Y, Wu W, He R, Lu Y, Zhang Y, Wang L, Zhang X. Using 4DCBCT simulation and guidance to evaluate inter-fractional tumor variance during SABR for lung tumor within the lower lobe. Sci Rep 2021;11:19976. [PMID: 34620950 DOI: 10.1038/s41598-021-99489-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Visser S, den Otter LA, Ribeiro CO, Korevaar EW, Both S, Langendijk JA, Muijs CT, Sijtsema NM, Knopf A. Diaphragm-Based Position Verification to Improve Daily Target Dose Coverage in Proton and Photon Radiation Therapy Treatment of Distal Esophageal Cancer. Int J Radiat Oncol Biol Phys 2021:S0360-3016(21)02814-5. [PMID: 34530091 DOI: 10.1016/j.ijrobp.2021.09.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Agüero H, Rojas-lópez JA, Mancuzo A, Binia S. OSL nanodot response at high dose gradient regions: Validation with phantom and in vivo tests. PROCEEDINGS OF THE XVI MEXICAN SYMPOSIUM ON MEDICAL PHYSICS 2021. [DOI: 10.1063/5.0051202] [Reference Citation Analysis]
8 Fleming C, Mcdermott R, O’keeffe S, Dunne M, Armstrong JG, Mcclean B, Vintró LL. Dose volume histogram metrics and tumour control probability modelling in locally advanced non-small-cell lung cancer: average intensity dataset versus individual four-dimensional CT phases. J Radiother Pract 2021;20:373-9. [DOI: 10.1017/s146039692000076x] [Reference Citation Analysis]
9 Chen M, Yang J, Liao Z, Chen J, Xu C, He X, Zhang X, Zhu RX, Li H. Anatomic change over the course of treatment for non-small cell lung cancer patients and its impact on intensity-modulated radiation therapy and passive-scattering proton therapy deliveries. Radiat Oncol 2020;15:55. [PMID: 32138753 DOI: 10.1186/s13014-020-01503-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
10 Chai H, Narita Y, Takagi M, Kudo M, Kimura T, Kattou K. Technical note: improved positioning protocol for patient setup accuracy in conventional radiotherapy for lung cancer. Radiol Phys Technol 2019;12:426-32. [PMID: 31549292 DOI: 10.1007/s12194-019-00537-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Kaplan LP, Elstrøm UV, Møller DS, Hoffmann L. Cone beam CT based dose calculation in the thorax region. Phys Imaging Radiat Oncol 2018;7:45-50. [PMID: 33458404 DOI: 10.1016/j.phro.2018.09.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
12 Guy CL, Weiss E, Che S, Jan N, Zhao S, Rosu-Bubulac M. Evaluation of Image Registration Accuracy for Tumor and Organs at Risk in the Thorax for Compliance With TG 132 Recommendations. Adv Radiat Oncol 2019;4:177-85. [PMID: 30706026 DOI: 10.1016/j.adro.2018.08.023] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
13 Braun LH, Welz S, Viehrig M, Heinzelmann F, Zips D, Gani C. Resolution of atelectasis during radiochemotherapy of lung cancer with serious implications for further treatment. A case report. Clin Transl Radiat Oncol 2018;9:1-4. [PMID: 29594243 DOI: 10.1016/j.ctro.2017.12.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Yang S, Lin C, Chang M, Zhang GG, Chou K, Chiou Y, Sun S, Lui L, Ho T, Huang T. Dose Verification for Tumor Motion with Different Treatment Planning Systems: A Dynamic Thorax Phantom Study. J Med Biol Eng 2018;38:46-54. [DOI: 10.1007/s40846-017-0367-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Sloth Møller D, Knap MM, Nyeng TB, Khalil AA, Holt MI, Kandi M, Hoffmann L. Difference in target definition using three different methods to include respiratory motion in radiotherapy of lung cancer. Acta Oncol 2017;56:1604-9. [PMID: 28885090 DOI: 10.1080/0284186X.2017.1373848] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
16 Zegers CML, Baeza JA, van Elmpt W, Murrer LHP, Verhoeven K, Boersma L, Verhaegen F, Nijsten SMJJG. Three-dimensional dose evaluation in breast cancer patients to define decision criteria for adaptive radiotherapy. Acta Oncol 2017;56:1487-94. [PMID: 28849731 DOI: 10.1080/0284186X.2017.1349334] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
17 . MRI-based IGRT for lung cancer. Principles and Practice of Image-Guided Radiation Therapy of Lung Cancer 2017. [DOI: 10.1201/9781315143873-23] [Reference Citation Analysis]
18 Guy CL, Weiss E, Jan N, Reshko LB, Christensen GE, Hugo GD. Effect of atelectasis changes on tissue mass and dose during lung radiotherapy. Med Phys 2016;43:6109. [PMID: 27806593 DOI: 10.1118/1.4965807] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
19 Kamerling CP, Fast MF, Ziegenhein P, Menten MJ, Nill S, Oelfke U. Real-time 4D dose reconstruction for tracked dynamic MLC deliveries for lung SBRT. Med Phys 2016;43:6072. [PMID: 27806589 DOI: 10.1118/1.4965045] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 6.2] [Reference Citation Analysis]
20 Tennyson N, Weiss E, Sleeman W, Rosu M, Jan N, Hugo GD. Effect of variations in atelectasis on tumor displacement during radiation therapy for locally advanced lung cancer. Adv Radiat Oncol 2017;2:19-26. [PMID: 28740912 DOI: 10.1016/j.adro.2016.12.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
21 Bolukbasi Y, Sezen D, Topkan E, Selek U. Modern Radiotherapy Techniques in Lung Cancer. Principles and Practice of Radiotherapy Techniques in Thoracic Malignancies 2016. [DOI: 10.1007/978-3-319-28761-4_2] [Reference Citation Analysis]
22 Berkovic P, Paelinck L, Lievens Y, Gulyban A, Goddeeris B, Derie C, Surmont V, De Neve W, Vandecasteele K. Adaptive radiotherapy for locally advanced non-small cell lung cancer, can we predict when and for whom? Acta Oncol 2015;54:1438-44. [PMID: 26405809 DOI: 10.3109/0284186X.2015.1061209] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
23 Grau C, Overgaard J, Høyer M, Tanderup K, Lindegaard JC, Muren LP. Biology-guided adaptive radiotherapy (BiGART) is progressing towards clinical reality. Acta Oncol 2015;54:1245-50. [PMID: 26390238 DOI: 10.3109/0284186X.2015.1076992] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
24 Sibolt P, Ottosson W, Sjöström D, Larsen C, Behrens CF. Adaptation requirements due to anatomical changes in free-breathing and deep-inspiration breath-hold for standard and dose-escalated radiotherapy of lung cancer patients. Acta Oncol 2015;54:1453-60. [PMID: 26206518 DOI: 10.3109/0284186X.2015.1062543] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
25 Tvilum M, Khalil AA, Møller DS, Hoffmann L, Knap MM. Clinical outcome of image-guided adaptive radiotherapy in the treatment of lung cancer patients. Acta Oncol 2015;54:1430-7. [PMID: 26206515 DOI: 10.3109/0284186X.2015.1062544] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 4.7] [Reference Citation Analysis]
26 Persoon LC, Podesta M, Hoffmann L, Sanizadeh A, Schyns LE, de Ruiter BM, Nijsten SM, Muren LP, Troost EG, Verhaegen F. Is integrated transit planar portal dosimetry able to detect geometric changes in lung cancer patients treated with volumetric modulated arc therapy? Acta Oncol 2015;54:1501-7. [PMID: 26179632 DOI: 10.3109/0284186X.2015.1061213] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
27 Thariat J, Lapierre A, Früh M, Mornex F. Advances in Radiotherapy for Locally Advanced NSCLC. New Therapeutic Strategies in Lung Cancers 2015. [DOI: 10.1007/978-3-319-06062-0_6] [Reference Citation Analysis]
28 Muren LP, Teräs M, Knuuti J. NACP 2014 and the Turku PET symposium: the interaction between therapy and imaging. Acta Oncol 2014;53:993-6. [PMID: 25141819 DOI: 10.3109/0284186X.2014.941073] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
29 Elstrøm UV, Olsen SR, Muren LP, Petersen JB, Grau C. The impact of CBCT reconstruction and calibration for radiotherapy planning in the head and neck region - a phantom study. Acta Oncol 2014;53:1114-24. [PMID: 24975372 DOI: 10.3109/0284186X.2014.927073] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
30 Vestergaard A, Muren LP, Lindberg H, Jakobsen KL, Petersen JB, Elstrøm UV, Agerbæk M, Høyer M. Normal tissue sparing in a phase II trial on daily adaptive plan selection in radiotherapy for urinary bladder cancer. Acta Oncol 2014;53:997-1004. [PMID: 24957559 DOI: 10.3109/0284186X.2014.928419] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 6.5] [Reference Citation Analysis]